Birdshot Chorioretinopathy
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Chorioretinitis1
- Multimodal Imaging1
- Uveitis1
Leading journals1
- American journal of ophthalmology1
Leading researchers8
- Agarwal A1
- Bodaghi B1
- Brézin AP1
- Fawzi A1
- Grewal DS1
- Gupta V1
- Jabs DA1
- Miserocchi E1
Affiliations (unnormalised)6
- Advanced Eye Centre (V.G.)1
- Center for Clinical Trials and Evidence Synthesis1
- Centre d'ophtalmologie de l'Assistance Publique - Hôpitaux de Paris (A.B.)1
- Cleveland Clinic Foundation (S.S.)1
- Duke University School of Medicine1
- From the Cleveland Clinic Abu Dhabi (F.P.1
Reference
Authoritative identity, definition & identifiers.
A form of chorioretinitis characterized by multiple small, cream-colored LESIONS, symmetrically scattered mainly around the OPTIC DISK. These lesions are the most distinctive sign and often appear at the level of the RETINAL PIGMENT EPITHELIUM but, on occasion, suggest an even deeper infiltration and may ultimately lead to visual loss. An association with HLA-A29 antigen (see HLA-A ANTIGENS) has been observed in nearly all patients.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.